MedPath

Risk Factors And Outcomes Of Hospital Acquired AKI

Completed
Conditions
AKI - Acute Kidney Injury
Interventions
Other: standard care for hospitalized patients
Other: standard AKI care bundle
Registration Number
NCT06051708
Lead Sponsor
Alexandria University
Brief Summary

The aim of the study is to assess the common risk factors for development of hospital acquired acute kidney injury among hospitalized patients in Alexandria Main University hospital and their outcomes.

Detailed Description

Hospital-acquired AKI (HAAKI) is defined as acute renal insult occurring 48 hours or more after admission to a health care facility and It is estimated to occur in 13-18% of hospitalized patients. The early diagnosis of HAAKI reflects on improvement in morbidity and mortality rates especially in developing countries which goes parallel with the goal The International Society of Nephrology (ISN) to eliminate preventable or treatable deaths from AKI by 2025, the "0 by 25" initiative.

Data concerning the spectrum of acute kidney injury (AKI) in Egypt are generally scarce.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. Fulfilment of definition of acute kidney injury according to KDIGO reference.
  2. Age more than 18 years.
Exclusion Criteria
  1. Mentally or physically unfit patients.
  2. Patients who developed acute kidney injury within 48 hours of admission to hospital.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
no AKI groupstandard care for hospitalized patientspatients who are hospitalized and do not develop acute kidney injury after 48 hours from admission till discharge
AKI groupstandard AKI care bundlepatients who are hospitalized and develop acute kidney injury after 48 hours from admission
Primary Outcome Measures
NameTimeMethod
Recovery of kidney functions12 weeks

(improvement of eGFR, serum creatinine to normal or previous baseline).

Secondary Outcome Measures
NameTimeMethod
Need for renal replacement therapy12 weeks

different modalities of RRT

mortality12 weeks

death

progression to chronic kidney disease.12 weeks

deterioration of kidney functions ( creatinine, eGFR)

Trial Locations

Locations (1)

Faculty of Medicine, Aexandria University

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath